StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)

Close on Nov 16, 2026Market cap $1.52BP/E –Yield –

GeneDx EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

GeneDx's EPS for the twelve months ending Jun 30, 2026 was -$3.64, down 18300.0% year over year. For fiscal 2025 it was -$0.73. The highest annual figure on record is -$0.73 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.73–
FY2024Dec 31, 2024-$1.94–
FY2023Dec 31, 2023-$7.23–
FY2022Dec 31, 2022-$53.63–
FY2021Dec 31, 2021-$74.91–
FY2020Dec 31, 2020-$1552188.00–
FY2019Dec 31, 2019-$8713848.00–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.60-266.7%
Q1 FY2026Mar 31, 2026-$2.16–
Q4 FY2025Dec 31, 2025-$0.61-405.0%
Q3 FY2025Sep 30, 2025-$0.27–
Q2 FY2025Jun 30, 2025$0.36–
Q1 FY2025Mar 31, 2025-$0.23–
Q4 FY2024Dec 31, 2024$0.20–
Q3 FY2024Sep 30, 2024-$0.31–
Q2 FY2024Jun 30, 2024-$1.10–
Q1 FY2024Mar 31, 2024-$0.78–
Q4 FY2023Dec 31, 2023-$0.99–
Q3 FY2023Sep 30, 2023-$1.64–
Q2 FY2023Jun 30, 2023-$1.84–
Q1 FY2023Mar 31, 2023-$3.04–
Q4 FY2022Dec 31, 2022-$26.34-598.9%
Q3 FY2022Sep 30, 2022-$6.72–
Q2 FY2022Jun 30, 2022-$8.38–
Q1 FY2022Mar 31, 2022-$10.38–
Q3 FY2021Sep 30, 2021$5.28–
Q2 FY2021Jun 30, 2021-$1384.02–
Q1 FY2021Mar 31, 2021-$11511.06–
Q3 FY2020Sep 30, 2020-$15066909.00–

More GeneDx figures

See a number that looks wrong?